[1]
V. Nayak, V. Devaramane, D. Mallya, and P. V. Bhandary, “Olanzapine induced hyperprolactinemia”, Int J Basic Clin Pharmacol, vol. 2, no. 6, pp. 836–837, Feb. 2017.